Richard F Spaide1, Glenn J Jaffe2, David Sarraf3, K Bailey Freund4, Srinivas R Sadda3, Giovanni Staurenghi5, Nadia K Waheed6, Usha Chakravarthy7, Philip J Rosenfeld8, Frank G Holz9, Eric H Souied10, Salomon Y Cohen11, Giuseppe Querques12, Kyoko Ohno-Matsui13, David Boyer14, Alain Gaudric15, Barbara Blodi16, Caroline R Baumal6, Xiaoxin Li17, Gabriel J Coscas18, Alexander Brucker19, Lawrence Singerman20, Phil Luthert21, Steffen Schmitz-Valckenberg9, Ursula Schmidt-Erfurth22, Hans E Grossniklaus23, David J Wilson24, Robyn Guymer25, Lawrence A Yannuzzi4, Emily Y Chew26, Karl Csaky27, Jordi M Monés28, Daniel Pauleikhoff29, Ramin Tadayoni15, James Fujimoto30. 1. Vitreous Retina Macula Consultants of New York, New York, New York. Electronic address: rickspaide@gmail.com. 2. Department of Ophthalmology, Duke University, Durham, North Carolina. 3. Doheny Eye Institute, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California. 4. Vitreous Retina Macula Consultants of New York, New York, New York. 5. San Raffaele Scientific Institute, Milan, Italy. 6. New England Eye Center, Tufts University, Boston, Massachusetts. 7. Center for Public Health, The Queen's University of Belfast, Belfast, United Kingdom. 8. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida. 9. Department of Ophthalmology, University of Bonn, Bonn, Germany. 10. Department of Ophthalmology, Université Paris-Est Créteil, Paris, France. 11. Ophthalmic Center for Imaging and Laser, Paris, France. 12. IRCCS San Raffaele Hospital, University Vita-Salute San Raffele, Milan, Italy. 13. Department of Ophthalmology, Tokyo Medical and Dental University, Tokyo, Japan. 14. Retina-Vitreous Associates Medical Group, Los Angeles, California. 15. Department of Ophthalmology, Hôpital Lariboisière, AP-HP, Université de Paris, Paris, France. 16. Department of Ophthalmology and Visual Sciences, Fundus Photograph Reading Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. 17. Department of Ophthalmology, People's Eye Center of People's Hospital of Beijing University, Beijing, China. 18. Department of Ophthalmology, University of Paris XII, Paris, France. 19. Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania. 20. Department of Ophthalmology, Case Western Reserve University School of Medicine, Cleveland, Ohio. 21. Institute of Ophthalmology, University College London, London, United Kingdom. 22. Department of Ophthalmology, University Eye Hospital, Vienna, Austria. 23. Emory Eye Center, Atlanta, Georgia. 24. Oregon Health Science University, Portland, Oregon. 25. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Department of Surgery (Ophthalmology), University of Melbourne, Melbourne, Australia. 26. National Eye Institute, National Institutes of Health, Bethesda, Maryland. 27. Texas Retina Associates, Dallas, Texas. 28. Institut de la Màcula and Barcelona Macula Foundation, Barcelona, Spain. 29. Department of Ophthalmology, St. Franziskus Hospital, Münster, Germany. 30. Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Abstract
PURPOSE: To establish a process to evaluate and standardize a state-of-the-art nomenclature for reporting neovascular age-related macular degeneration (AMD) data. DESIGN: Consensus meeting. PARTICIPANTS: An international panel of retina specialists, imaging and image reading center experts, and ocular pathologists. METHODS: During several meetings organized under the auspices of the Macula Society, an international study group discussed and codified a set nomenclature framework for classifying the subtypes of neovascular AMD and associated lesion components. MAIN OUTCOME MEASURES: A consensus classification of neovascular AMD. RESULTS: The study group created a standardized working definition of AMD. The components of neovascular AMD were defined and subclassified. Disease consequences of macular neovascularization were delineated. CONCLUSIONS: The framework of a consensus nomenclature system, a definition of AMD, and a delineation of the subtypes of neovascular AMD were developed. Establishing a uniform set of definitions will facilitate comparison of diverse patient groups and different studies. The framework presented is modified and updated readily, processes that are anticipated to occur on a periodic basis. The study group suggests that the consensus standards outlined in this article be used in future reported studies of neovascular AMD and clinical practice.
PURPOSE: To establish a process to evaluate and standardize a state-of-the-art nomenclature for reporting neovascular age-related macular degeneration (AMD) data. DESIGN: Consensus meeting. PARTICIPANTS: An international panel of retina specialists, imaging and image reading center experts, and ocular pathologists. METHODS: During several meetings organized under the auspices of the Macula Society, an international study group discussed and codified a set nomenclature framework for classifying the subtypes of neovascular AMD and associated lesion components. MAIN OUTCOME MEASURES: A consensus classification of neovascular AMD. RESULTS: The study group created a standardized working definition of AMD. The components of neovascular AMD were defined and subclassified. Disease consequences of macular neovascularization were delineated. CONCLUSIONS: The framework of a consensus nomenclature system, a definition of AMD, and a delineation of the subtypes of neovascular AMD were developed. Establishing a uniform set of definitions will facilitate comparison of diverse patient groups and different studies. The framework presented is modified and updated readily, processes that are anticipated to occur on a periodic basis. The study group suggests that the consensus standards outlined in this article be used in future reported studies of neovascular AMD and clinical practice.
Authors: Almut Bindewald-Wittich; Joanna Dolar-Szczasny; Sandrine H Kuenzel; Leon von der Emde; Maximilian Pfau; Robert Rejdak; Steffen Schmitz-Valckenberg; Thomas Ach; Jens Dreyhaupt; Frank G Holz Journal: Eye (Lond) Date: 2022-05-17 Impact factor: 3.775
Authors: Christopher K Hwang; Elvira Agrón; Amitha Domalpally; Catherine A Cukras; Wai T Wong; Emily Y Chew; Tiarnan D L Keenan Journal: Ophthalmol Retina Date: 2020-10-16